Aurinia Pharmaceuticals AUPH Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's change in AP?
- Aurinia Pharmaceuticals (AUPH) reported change in AP of -$652K in Q1 2026.
- How has Aurinia Pharmaceuticals's change in AP changed year-over-year?
- Aurinia Pharmaceuticals's change in AP increased by 33.1% year-over-year, from -$974K to -$652K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.